Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Burris

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
ACS Chemical Neuroscience|April 13, 2024
Catharanthine Modulates Mesolimbic Dopamine Transmission and Nicotine Psychomotor Effects via Inhibition of α6-Nicotinic Receptors and Dopamine TransportersBenjamin M Williams, Nathan D Steed, Joel T Woolley, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
2-arylaminothiazoles as high-affinity corticotropin-releasing factor 1 receptor (CRF1R) antagonists: synthesis, binding studies and behavioral efficacyGene M Dubowchik, Jodi A Michne, Dmitry Zuev, et al.
The American Journal of Pathology|February 3, 2026
Leukocytic Dopamine D2 Receptors as Biomarkers for Brain Dopamine Levels in Parkinson's DiseaseChristina A Nelson, J Daniel Obray, Charles R Roll, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 27, 2019
Modulation of TARP <i>γ</i>8-Containing AMPA Receptors as a Novel Therapeutic Approach for Chronic PainKelly L Knopp, Rosa Maria A Simmons, Wenhong Guo, et al.
Nature Medicine|November 8, 2016
Forebrain-selective AMPA-receptor antagonism guided by TARP γ-8 as an antiepileptic mechanismAkihiko S Kato, Kevin D Burris, Kevin M Gardinier, et al.
Journal of Medicinal Chemistry|April 13, 2016
Discovery of the First α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonist Dependent upon Transmembrane AMPA Receptor Regulatory Protein (TARP) γ-8Kevin M Gardinier, Douglas L Gernert, Warren J Porter, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
ACS Chemical Neuroscience|April 13, 2024
Catharanthine Modulates Mesolimbic Dopamine Transmission and Nicotine Psychomotor Effects via Inhibition of α6-Nicotinic Receptors and Dopamine TransportersBenjamin M Williams, Nathan D Steed, Joel T Woolley, et al.
Bioorganic & Medicinal Chemistry Letters|November 1, 2003
2-arylaminothiazoles as high-affinity corticotropin-releasing factor 1 receptor (CRF1R) antagonists: synthesis, binding studies and behavioral efficacyGene M Dubowchik, Jodi A Michne, Dmitry Zuev, et al.
The American Journal of Pathology|February 3, 2026
Leukocytic Dopamine D2 Receptors as Biomarkers for Brain Dopamine Levels in Parkinson's DiseaseChristina A Nelson, J Daniel Obray, Charles R Roll, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 27, 2019
Modulation of TARP <i>γ</i>8-Containing AMPA Receptors as a Novel Therapeutic Approach for Chronic PainKelly L Knopp, Rosa Maria A Simmons, Wenhong Guo, et al.
Nature Medicine|November 8, 2016
Forebrain-selective AMPA-receptor antagonism guided by TARP γ-8 as an antiepileptic mechanismAkihiko S Kato, Kevin D Burris, Kevin M Gardinier, et al.
Journal of Medicinal Chemistry|April 13, 2016
Discovery of the First α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonist Dependent upon Transmembrane AMPA Receptor Regulatory Protein (TARP) γ-8Kevin M Gardinier, Douglas L Gernert, Warren J Porter, et al.
Pageof 8